SCHEMBL4718362

SCHEMBL4718362

CNC(C(C)O)N1CC(C)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 10/20 0.47
SLC6A4 P31645 10/20 0.47
NOTUM Q6P988 1/20 0.44
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
ROCK1 Q13464 1/20 0.35
TSHR P16473 1/20 0.35
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
HRH1 P35367 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13823637 0.77 NOTUM (0.50) SLC6A2SLC6A4NOTUMALDH1A1CYP3A4
SCHEMBL5848884 0.72 SLC6A2 (0.45) SLC6A2SLC6A4NOTUMALDH1A1CYP3A4
SCHEMBL13180794 0.72 NOTUM (0.45) SLC6A2SLC6A4NOTUMALDH1A1CYP3A4
SCHEMBL13888901 0.70 SLC6A2 (0.78) SLC6A2SLC6A4
SCHEMBL2625781 0.68 NOTUM (0.55) SLC6A2SLC6A4NOTUMCYP3A4CYP2D6
SCHEMBL22240446 0.68 NOTUM (0.55) SLC6A2SLC6A4NOTUMCYP3A4CYP2D6
SCHEMBL18681421 0.68 NOTUM (0.55) SLC6A2SLC6A4NOTUMCYP3A4CYP2D6
SCHEMBL13372442 0.68 NOTUM (0.55) SLC6A2SLC6A4NOTUMCYP3A4CYP2D6
SCHEMBL14218868 0.67 NOTUM (0.50) SLC6A2SLC6A4NOTUMALDH1A1ROCK1
SCHEMBL20467040 0.66 NOTUM (0.41) SLC6A2SLC6A4NOTUMALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931631-A1 1- (1H- INDOL- 1-YL) -3- (METHYLAMINO) -1- PHENYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) Wyeth a Corporation of the State of Delaware (US) 2008-06-18 EP disclosed
WO-2007041023-A1 1- (1H- INDOL- 1-YL) -3- (METHYLAMINO) -1- PHENYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) WYETH (US) 2007-04-12 WO disclosed